Clinical Trials Logo

Clinical Trial Summary

As Covid 19 manifestations that have been recently described, inflammatory manifestation have major impact in infectious disease lesions. Some of them are delayed and provide Post infectious inflammatory reaction (PIIR), they are challenging for diagnosis and for management. Clinician have to avoid unnecessary antibiotic thearapy and in if necessary have to give immunosuppressive therapy. Except for rheumatic disease for group A streptococcus (GAS) infections there are not stanrdized diagnostic criteria and therapeutic protocol, and PIIR have probably a suboptimal management. In this context the investigators aim to explore PIIR in the 3 most frequent bacterial invasive infection in France, by a retrospective monocentric study. The investigators include all children betwwen 2012 and 2018 hospitalized for infections by Streptococcus pneumoniae (SP), Neisseria meningitidis (NM), and GAS invasive infections.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04594785
Study type Observational
Source University Hospital, Montpellier
Contact Eric JEZIORSKI
Phone 04 67 33 57 98
Email e-jeziorski@chu-montpellier.fr
Status Recruiting
Phase
Start date October 1, 2020
Completion date December 30, 2021

See also
  Status Clinical Trial Phase
Completed NCT00471757 - Etiology of Community Acquired Pneumonia
Recruiting NCT04974294 - PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2) Phase 4
Not yet recruiting NCT05140720 - Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age N/A
Recruiting NCT05535868 - Experimental Human Pneumococcal Challenge With SPN3 N/A
Recruiting NCT05429541 - Pneumococcal Carriage and Serotype Distribution in Children With Otitis Media in Malaysia.
Completed NCT00808821 - Pharyngeal Carriage Rates and Genetic Typing of Group A Streptococcus and Streptococcus Pneumonia Among Israeli Military Basic Trainees N/A